Our data suggest that ERp57 contributes to radioresistance of laryngeal cancer cells by activating the STAT3-Mcl-1 pathway, and this regulation is associated with poor prognosis in laryngeal cancer. Here, MCL1 is linked to laryngeal carcinoma.